Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2010 | 1 |
2011 | 2 |
2014 | 1 |
2018 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases.
Biomedicines. 2020 Apr 3;8(4):74. doi: 10.3390/biomedicines8040074.
Biomedicines. 2020.
PMID: 32260271
Free PMC article.
Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals.
Sugiura A, Joshita S, Umemura T, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Usami Y, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Kiyosawa K, Tanaka E.
Sugiura A, et al. Among authors: koike y.
J Viral Hepat. 2018 Dec;25(12):1462-1471. doi: 10.1111/jvh.12973. Epub 2018 Aug 30.
J Viral Hepat. 2018.
PMID: 30044517
Item in Clipboard
2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease.
Kato A, Yamashita Y, Nakagawa S, Koike Y, Adachi I, Hollinshead J, Nash RJ, Ikeda K, Asano N.
Kato A, et al. Among authors: koike y.
Bioorg Med Chem. 2010 Jun 1;18(11):3790-4. doi: 10.1016/j.bmc.2010.04.048. Epub 2010 Apr 21.
Bioorg Med Chem. 2010.
PMID: 20457528
Item in Clipboard
Looking-glass synergistic pharmacological chaperones: DGJ and L-DGJ from the enantiomers of tagatose.
Jenkinson SF, Fleet GW, Nash RJ, Koike Y, Adachi I, Yoshihara A, Morimoto K, Izumori K, Kato A.
Jenkinson SF, et al. Among authors: koike y.
Org Lett. 2011 Aug 5;13(15):4064-7. doi: 10.1021/ol201552q. Epub 2011 Jul 11.
Org Lett. 2011.
PMID: 21744786
Item in Clipboard
Docking and SAR studies of calystegines: binding orientation and influence on pharmacological chaperone effects for Gaucher's disease.
Kato A, Nakagome I, Nakagawa S, Koike Y, Nash RJ, Adachi I, Hirono S.
Kato A, et al. Among authors: koike y.
Bioorg Med Chem. 2014 Apr 15;22(8):2435-41. doi: 10.1016/j.bmc.2014.02.057. Epub 2014 Mar 12.
Bioorg Med Chem. 2014.
PMID: 24657053
Item in Clipboard
Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients.
Yoneda S, Umemura T, Katsuyama Y, Kamijo A, Joshita S, Komatsu M, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E; Nagano Interferon Treatment Research Group.
Yoneda S, et al.
J Infect Dis. 2011 Apr 15;203(8):1087-95. doi: 10.1093/infdis/jiq165. Epub 2011 Mar 11.
J Infect Dis. 2011.
PMID: 21398397
Free article.
Item in Clipboard
Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors.
Shirakawa H, Matsumoto A, Joshita S, Komatsu M, Tanaka N, Umemura T, Ichijo T, Yoshizawa K, Kiyosawa K, Tanaka E; Nagano Interferon Treatment Research Group.
Shirakawa H, et al.
Hepatology. 2008 Dec;48(6):1753-60. doi: 10.1002/hep.22543.
Hepatology. 2008.
PMID: 18925643
Item in Clipboard
Cite
Cite